209 related articles for article (PubMed ID: 19717384)
21. Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysis.
Kagoya Y; Nannya Y; Kurokawa M
Leuk Res; 2012 Aug; 36(8):1016-21. PubMed ID: 22579366
[TBL] [Abstract][Full Text] [Related]
22. Bradycardia during therapy for multiple myeloma with thalidomide.
Fahdi IE; Gaddam V; Saucedo JF; Kishan CV; Vyas K; Deneke MG; Razek H; Thorn B; Bissett JK; Anaissie EJ; Barlogie B; Mehta JL
Am J Cardiol; 2004 Apr; 93(8):1052-5. PubMed ID: 15081457
[TBL] [Abstract][Full Text] [Related]
23. Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
Badros A; Goloubeva O; Dalal JS; Can I; Thompson J; Rapoport AP; Heyman M; Akpek G; Fenton RG
Cancer; 2007 Sep; 110(5):1042-9. PubMed ID: 17654660
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma.
Raje N; Hideshima T; Anderson KC
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1239-47. PubMed ID: 17020458
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis.
Uaprasert N; Voorhees PM; Mackman N; Key NS
Eur J Cancer; 2010 Jul; 46(10):1790-9. PubMed ID: 20385482
[TBL] [Abstract][Full Text] [Related]
26. Neutrophilic dermatosis complicating lenalidomide therapy.
Thieu KP; Rosenbach M; Xu X; Kist JM
J Am Acad Dermatol; 2009 Oct; 61(4):709-10. PubMed ID: 19577327
[TBL] [Abstract][Full Text] [Related]
27. Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.
Hazarika M; Rock E; Williams G; Dagher R; Sridhara R; Booth B; Farrell A; Justice R; Pazdur R
Oncologist; 2008 Oct; 13(10):1120-7. PubMed ID: 18922829
[TBL] [Abstract][Full Text] [Related]
28. Thalidomide therapy and deep venous thrombosis in multiple myeloma.
Rajkumar SV
Mayo Clin Proc; 2005 Dec; 80(12):1549-51. PubMed ID: 16350272
[No Abstract] [Full Text] [Related]
29. Thalidomide and dexamethasone: therapy for multiple myeloma.
Kumar S; Rajkumar SV
Expert Rev Anticancer Ther; 2005 Oct; 5(5):759-66. PubMed ID: 16221046
[TBL] [Abstract][Full Text] [Related]
30. Treatment of multiple myeloma and arterial thrombosis.
Raven W; Berghout A; van Houten A; Leebeek FW
Ann Hematol; 2010 Apr; 89(4):419-20. PubMed ID: 19688212
[No Abstract] [Full Text] [Related]
31. Thalidomide and thrombosis. A meta-analysis.
El Accaoui RN; Shamseddeen WA; Taher AT
Thromb Haemost; 2007 Jun; 97(6):1031-6. PubMed ID: 17549307
[TBL] [Abstract][Full Text] [Related]
32. Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: case report and review of literature.
Prasad HK; Kaushal V; Mehta P
Am J Hematol; 2007 Sep; 82(9):855-7. PubMed ID: 17570510
[TBL] [Abstract][Full Text] [Related]
33. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.
Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795
[TBL] [Abstract][Full Text] [Related]
34. Anticoagulation regimens for thalidomide and lenalidomide.
Zangari M
Clin Adv Hematol Oncol; 2006 Sep; 4(9):658-9. PubMed ID: 17099621
[No Abstract] [Full Text] [Related]
35. Update of thrombosis in multiple myeloma.
Leebeek FW
Thromb Res; 2016 Apr; 140 Suppl 1():S76-80. PubMed ID: 27067983
[TBL] [Abstract][Full Text] [Related]
36. Cerebral venous thrombosis in an individual with multiple myeloma treated with lenalidomide.
Eudo C; Petit A; Mondon K; Rippault H; Dardaine V; Constans T; Hommet C; Cottier JP
J Am Geriatr Soc; 2011 Dec; 59(12):2371-2. PubMed ID: 22188080
[No Abstract] [Full Text] [Related]
37. Lenalidomide, a thalidomide derivative, shows promise in various applications.
Oestreicher P
ONS Connect; 2007 Aug; 22(8):22-3. PubMed ID: 17824579
[No Abstract] [Full Text] [Related]
38. Monotherapy with low-dose thalidomide for relapsed or refractory multiple myeloma: better response rate with earlier treatment.
Maisnar V; Radocha J; Büchler T; Bláha V; Malý J; Hájek R
Eur J Haematol; 2007 Oct; 79(4):305-9. PubMed ID: 17803678
[TBL] [Abstract][Full Text] [Related]
39. Thalidomide in the treatment of multiple myeloma.
Kastritis E; Dimopoulos MA
Best Pract Res Clin Haematol; 2007 Dec; 20(4):681-99. PubMed ID: 18070713
[TBL] [Abstract][Full Text] [Related]
40. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
Musallam KM; Dahdaleh FS; Shamseddine AI; Taher AT
Thromb Res; 2009 Mar; 123(5):679-86. PubMed ID: 18992924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]